nitroxyl has been researched along with Colitis in 4 studies
nitroxyl: hydroxamic acid oxidized to nitroxyl free radical
nitroxyl : A nitrogen oxoacid consisting of an oxygen atom double-bonded to an NH group.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Excerpt | Relevance | Reference |
---|---|---|
" Here, the antioxidant capacity and protective effects of a new class of chemically modified hetastarch (polynitroxyl starch, or PNS) plus 4-hydroxyl-2,2,6,6-tetramethylpiperidine-N-oxyl (Tempol or TPL) (PNS/TPL) were assessed in a model of colitis." | 7.71 | Polynitroxylated starch/TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis. ( Alexander, JS; Carter, P; Coe, L; Grisham, MB; Hsia, CJ; Liu, JE; Ma, JW; Ma, L; Oshima, T; Park, JH; Specian, R; Trimble, CE, 2002) |
" The effects of RNP(O) were determined in mice with dextran sodium sulfate (DSS)-induced colitis and compared with those of low-molecular-weight drugs (4-hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl [TEMPOL] or mesalamine)." | 3.78 | An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice. ( Matsui, H; Nagasaki, Y; Tomita, T; Vong, LB; Yoshitomi, T, 2012) |
" Here, the antioxidant capacity and protective effects of a new class of chemically modified hetastarch (polynitroxyl starch, or PNS) plus 4-hydroxyl-2,2,6,6-tetramethylpiperidine-N-oxyl (Tempol or TPL) (PNS/TPL) were assessed in a model of colitis." | 3.71 | Polynitroxylated starch/TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis. ( Alexander, JS; Carter, P; Coe, L; Grisham, MB; Hsia, CJ; Liu, JE; Ma, JW; Ma, L; Oshima, T; Park, JH; Specian, R; Trimble, CE, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hossain, MA | 1 |
Yamashita, M | 1 |
Vong, LB | 3 |
Ikeda, Y | 1 |
Nagasaki, Y | 3 |
Yoshitomi, T | 2 |
Matsui, H | 2 |
Tomita, T | 1 |
Park, JH | 1 |
Ma, L | 1 |
Oshima, T | 1 |
Carter, P | 1 |
Coe, L | 1 |
Ma, JW | 1 |
Specian, R | 1 |
Grisham, MB | 1 |
Trimble, CE | 1 |
Hsia, CJ | 1 |
Liu, JE | 1 |
Alexander, JS | 1 |
4 other studies available for nitroxyl and Colitis
Article | Year |
---|---|
Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Colitis; Colon; Delayed-Action Pre | 2014 |
Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Azoxymethane; Camptothecin; Cell Line, Tumor; | 2015 |
An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Colitis; Colon | 2012 |
Polynitroxylated starch/TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis.
Topics: Adult; Animals; Antioxidants; Body Weight; Cachexia; Cell Adhesion; Colitis; Cyclic N-Oxides; Diseas | 2002 |